In a new study, researchers evaluated the potential relationship between disordered eating attitudes and nutritional status ...

A new literature review explores the emerging application of CAR-T cell therapy in treating people with Systemic Lupus ...

Caribou Biosciences, Inc.’s CRBU share price has surged by 5.65%, which has investors questioning if this is right time to ...

Living in areas with lower COI levels was associated with more severe disease presentation and poorer disease control among patients with cSLE.

Children born to anti-Ro antibody-positive mothers do not exhibit a greater prevalence of allergic, neurodevelopmental, or autoimmune conditions.

Despite executing "perfectly," Octagon confronted a “scientific no-go,” CEO Isaac Stoner said in his LinkedIn post announcing ...

Fate Therapeutics, Inc.’s FATE share price has dipped by 5.20%, which has investors questioning if this is right time to buy.

("Aurinia" or the "Company") (NASDAQ: AUPH) today announced that leading independent proxy advisor Institutional Shareholder ...

Octagon Therapeutics has thrown in the towel. The Novo Nordisk-allied autoimmune disease biotech is winding down after deprioritizing its lead program and running into unresolved biology questions.

Former Made In Chelsea star Louise Thompson has revealed she suffered a miscarriage last January. She shared the ...

Persistent exhaustion affects 1 in 4 Americans, yet many struggle for years without diagnosis. Discover the overlooked causes ...